Share

December 2018; 8 (6) Research

Electronic health record cue identifies epilepsy patients at risk for obstructive sleep apnea

Martha A. Mulvey, Aravindhan Veerapandiyan, David A. Marks, Xue Ming
First published August 23, 2018, DOI: https://doi.org/10.1212/CPJ.0000000000000502
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
109

Share

Article Information

vol. 8 no. 6 468-471
DOI: 
https://doi.org/10.1212/CPJ.0000000000000502
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received February 23, 2018
  • Accepted May 21, 2018
  • First Published August 23, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Martha A. Mulvey, DNP, ANP, BC,
    2. Aravindhan Veerapandiyan, MBBS,
    3. David A. Marks, MD and
    4. Xue Ming, MD, PhD
  1. Martha A. Mulvey, DNP, ANP, BC,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Aravindhan Veerapandiyan, MBBS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. David A. Marks, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Sunovion Pharmaceuticals - Commercial entity

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Xue Ming, MD, PhD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Journal of Pediatric Neurology, USA Editor, 3 years (2) Journal of Sleep Disorders and Therapy, Editorial board, 5 years

    Patents:

    1. (1) Polyunsaturated fatty acids interactions and oxidative stress disorders

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (MAM, DAM, XM), Rutgers New Jersey Medical School, Newark; and Department of Neurology (AV), University of Rochester Medical Center, NY.
  1. Correspondence
    Dr. Ming mingxu{at}njms.rutgers.edu
View Full Text

Article usage

Article usage: August 2018 to July 2022

AbstractFullPdfSource
Aug 20187804Highwire
Sep 201822908Highwire
Oct 201811209Highwire
Nov 20187904Highwire
Dec 20185162715Highwire
Jan 20193931012Highwire
Feb 201929925Highwire
Mar 201922545Highwire
Apr 201929644Highwire
May 2019293211Highwire
Jun 201925117Highwire
Jul 201933812Highwire
Aug 201962374Highwire
Sep 201958713Highwire
Oct 201954812Highwire
Nov 201937741Highwire
Dec 201922801Highwire
Jan 20207810Highwire
Feb 20204210Highwire
Mar 20207200Highwire
Apr 20204210Highwire
May 20204221Highwire
Jun 20204700Highwire
Jul 20201510Highwire
Aug 20201100Highwire
Sep 20205322Highwire
Oct 20203700Highwire
Nov 20209200Highwire
Dec 20203831Highwire
Jan 2021611Highwire
Feb 20211700Highwire
Mar 20213811Highwire
Apr 20213000Highwire
May 20212620Highwire
Jun 20214000Highwire
Jul 20213311Highwire
Aug 20213800Highwire
Sep 20212921Highwire
Oct 20213500Highwire
Nov 20213400Highwire
Dec 20213310Highwire
Jan 20223320Highwire
Feb 20224501Highwire
Mar 20225500Highwire
Apr 20224000Highwire
May 20224210Highwire
Jun 20222722Highwire
Jul 20222401Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me